IP Library Granted Patent US 9,637,469
Granted Patent B2
US 9,637,469 · App. 14/441,074 · Granted May 2, 2017

Pyridine derivative

Inventors: Akinobu Maruyama (Hino, JP); Hirofumi Kamada (Hino, JP); Mika Fujinuma (Chiyoda-ku, JP); Susumu Takeuchi (Hino, JP); Hiroshi Saitoh (Hino, JP); Yoshimasa Takahashi (Hino, JP)
Assignee: Teijin Pharma Limited
C07D401/04A61K31/4439C07D401/12C07D409/14C07D491/048
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,637,469
App. No.
14/441,074
Granted
May 2, 2017
Kind
B2
Abstract

Provided is a pyridine derivative represented by formula (I), a prodrug thereof, a pharmaceutically acceptable salt of the pyridine derivative or the prodrug, or a solvate of the pyridine derivative, the prodrug or the pharmaceutically acceptable salt, which is useful for treatment or prophylaxis of diseases associated with URAT1 such as gout, hyperuricemia, hypertension, kidney diseases such as interstitial nephritis, diabetes, arteriosclerosis and Lesch-Nyhan syndrome.

Claims (146)

1. A pyridine derivative represented by the following formula (I) or a pharmaceutically acceptable salt thereof,

wherein:

A represents a single bond;

R 1 represents a nitrogen atom, X 2 is N; X 1 , X 3 , X 4 and X 5 are CR 2 ;

R 2 each independently represent a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, a halogen atom, a trifluoromethyl group, a difluoromethyl group, a cyano group, an alkylcarbonyl group having 2 to 7 carbon atoms, an alkylsulfonyl group having 1 to 6 carbon atoms, a nitro group, an amino group, a dialkylamino group having 1 to 6 carbon atoms, a formyl group, a hydroxyl group, an alkoxy group having 1 to 6 carbon atoms (which may optionally be substituted with one or more of a hydroxyl group, a phenyl group, a cyclohexyl group, and a halogen atom), an alkylthio group having 1 to 6 carbon atoms, a phenyl group (which may optionally be substituted with one or more of an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, and a halogen atom), or a phenoxy group (which may optionally be substituted with one or more of an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, and a halogen atom);

R 3 represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms (which may optionally be substituted with one or more of a hydroxyl group, an amino group, a dialkylamino group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms (which may optionally be substituted with one or more of a hydroxyl group and a halogen atom), an alkylcarbonyl group having 2 to 7 carbon atoms, an alkylthio group having 1 to 6 carbon atoms, an alkylsulfinyl group having 1 to 6 carbon atoms, a halogen atom, a trifluoromethyl group, a difluoromethyl group, a cyano group, a phenyl group (which may optionally be substituted with one or more of an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, and a halogen atom), a phenoxy group (which may optionally be substituted with one or more of an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, and a halogen atom), a carboxyl group, or —CO 2 R 5 ;

R 4 represents a carboxyl group, —CONHSO 2 R 5 , —CO 2 R 5 , or any of the following substituents:

R 5 in R 3 and R 4 each independently represents an alkyl group having 1 to 6 carbon atoms;

Z represents any of the following substituents designated Z1 to Z2:

wherein:

R 6 and R 7 each independently represent a hydrogen atom, a halogen atom, an alkyl group having 1 to 6 carbon atoms, a trifluoromethyl group, a trifluoromethoxy group, or a cyano group, with the proviso that the case where R 6 and R 7 are simultaneously hydrogen atoms is excluded;

R 8 represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 6 carbon atoms, or a trifluoromethyl group; and

Y represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms.

2. The pyridine derivative or the pharmaceutically acceptable salt thereof, according to claim 1 , wherein, among four CR 2 's, three are CH's and R 2 of the remaining one CR 2 is a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, a halogen atom, a trifluoromethyl group, a difluoromethyl group, a cyano group, a nitro group, a dialkylamino group having 1 to 6 carbon atoms a hydroxyl group, an alkoxy group having 1 to 6 carbon atoms (which may optionally be substituted with one or more of a hydroxyl group, a phenyl group, a cyclohexyl group, and a halogen atom), an alkylthio group having 1 to 6 carbon atoms, a phenyl group (which may optionally be substituted with one or more of an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, and a halogen atom), or a phenoxy group (which may optionally be substituted with one or more of an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, and a halogen atom).

3. The pyridine derivative or the pharmaceutically acceptable salt thereof, according to claim 2 , wherein R 2 is a hydrogen atom, a methyl group, an ethyl group, a cyclopropyl group, a methoxy group, an ethoxy group, a propoxy group, an isopropoxy group, an isobutyloxy group, a benzyloxy group, a methylthio group, a fluorine atom, a chlorine atom, a bromine atom, a cyano group, a hydroxyl group, a trifluoromethyl group, a difluoromethyl group, a nitro group, a phenyl group, or a phenoxy group.

4. The pyridine derivative or the pharmaceutically acceptable salt thereof according to claim 1 , wherein, among four CR 2 's, three are CH's and the remaining CR 2 is located at X 4 .

5. The pyridine derivative or the pharmaceutically acceptable salt thereof, according to claim 1 , wherein R 3 is a hydrogen atom, an alkyl group having 1 to 6 carbon atoms (which may optionally be substituted with one or more of a hydroxyl group, an amino group, a dialkylamino group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, an alkylthio group having 1 to 6 carbon atoms, a halogen atom, a trifluoromethyl group, a difluoromethyl group, a cyano group, a phenyl group (which may optionally be substituted with one or more of an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, and a halogen atom), a carboxyl group, or —CO 2 R 5 .

6. The pyridine derivative or the pharmaceutically acceptable salt thereof, according to claim 5 , wherein R 3 is a hydrogen atom, a methyl group, an ethyl group, an isopropyl group, a cyclopropyl group, a chlorine atom, a bromine atom, an iodine atom, a trifluoromethyl group, a difluoromethyl group, a methoxy group, a phenyl group, a cyano group, a carboxyl group, —CO 2 R 5 , a hydroxymethyl group, a 1-hydroxyethyl group, a 2-hydroxypropan-2-yl group, a 3-hydroxypentan-3-yl group, a dimethylaminomethyl group, or a diethylaminomethyl group.

7. The pyridine derivative or the pharmaceutically acceptable salt thereof, according to claim 1 , wherein R 4 is a carboxyl group —CONHSO 2 CH 3 , —CONHSO 2 -cyclopropyl, or —CO 2 R 5 .

8. The pyridine derivative or the pharmaceutically acceptable salt thereof, according to claim 1 , wherein Z is Z1, and R 6 and R 7 are, on a phenyl ring, chlorine substituents at 2- and 5-positions, chlorine substituents at 3- and 5-positions, methyl substituents at 2- and 5-positions, trifluoromethyl substituents at 2- and 5-positions, or chlorine and methyl substituents at 2- and 5-positions, respectively; or

Z is Z2, and R 8 is, on a naphthalene ring, a hydrogen atom, a 2-methyl group, a 4-methyl group, an 8-methyl group, or an 8-bromo group.

9. A pyridine derivative selected from the following compounds (1) to (193) or a pharmaceutically acceptable salt thereof:

(1) 1-(2,5-dimethylbenzyl)-4-methyl-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(2) 4-methyl-1-(naphthalen-1-ylmethyl)-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(3) ethyl 4-methyl-1-(naphthalen-1-ylmethyl)-2-(pyridin-3-yl)-1H-imidazole-5-carboxylate;

(7) 4-chloro-1-(naphthalen-1-ylmethyl)-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(8) 4-ethyl-1-(naphthalen-1-ylmethyl)-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(9) 4-cyclopropyl-1-(naphthalen-1-ylmethyl)-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(10) 1-(2,5-dichlorobenzyl)-4-methyl-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(11) 1-(2,5-dichlorobenzyl)-4-ethyl-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(12) 4-cyclopropyl-1-(2,5-dichlorobenzyl)-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(13) 4-methyl-1-((4-methylnaphthalen-1-yl) methyl)-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(14) 4-cyclopropyl-1-((4-methylnaphthalen-1-yl)methyl)-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(15) 1-(2,5-dichlorobenzyl)-2-(pyridin-3-yl)-4-(trifluoromethyl)-1H-imidazole-5-carboxylic acid;

(17) 4-chloro-1-((4-methylnaphthalen-1-yl)methyl)-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(18) 4-isopropyl-1-(naphthalen-1-ylmethyl)-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(19) 4-isopropyl-1-((4-methylnaphthalen-1-yl)methyl)-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(20) 1-(2,5-dichlorobenzyl)-4-isopropyl-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(31) 1-(2-chloro-5-fluorobenzyl)-4-methyl-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(32) 1-(5-chloro-2-fluorobenzyl)-4-methyl-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(33) 1-(2-chloro-5-(trifluoromethyl)benzyl)-4 methyl-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(34) 1-(5-chloro-2-(trifluoromethyl)benzyl)-4-methyl-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(35) 1-(2,5-dichlorobenzyl)-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(36) 1-(2,5-bis(trifluoromethyl)benzyl)-4-methyl-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(37) 1-(2-bromobenzyl)-4-methyl-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(38) 1-(3-bromobenzyl)-4-methyl-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(40) 1-(3,4-dichlorobenzyl)-4-methyl-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(41) 1-(2,3-dichlorobenzyl)-4-methyl-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(42) 1-(3,5-dichlorobenzyl)-4-methyl-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(43) 1-(3-chloro-5-fluorobenzyl)-4-methyl-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(44) 1-(2,4-dichlorobenzyl)-4-methyl-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(45) 1-(2-chloro-5-methylbenzyl)-4-methyl-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(54) 4-chloro-1-(2,5-dichlorobenzyl)-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(55) 4-bromo-1-(2,5-dichlorobenzyl)-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(56) 1-(2,5-dichlorobenzyl)-4-iodo-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(57) 1-(2,5-dichlorobenzyl)-4-phenyl-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(58) 1-(2,5-dichlorobenzyl)-4-(3-fluorophenyl)-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(59) 1-(2,5-dichlorobenzyl)-4-(4-fluorophenyl)-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(61) 1-(2,5-dichlorobenzyl)-4-methoxy-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(62) 1-(2,5-dichlorobenzyl)-2-(pyridin-3-yl)-4-(2,2,2-trifluoroethoxy)-1H-imidazole-5-carboxylic acid;

(63) 1-(2,5-dichlorobenzyl)-2-(pyridin-3-yl)-4-(p-tolyloxy)-1H-imidazole-5-carboxylic acid;

(64) 1-(2,5-dichlorobenzyl)-4-(4-fluorophenoxy)-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(65) 4-cyano-1-(2,5-dichlorobenzyl)-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(66) 1-(2,5-dichlorobenzyl)-2-(pyridin-3-yl)-4-vinyl-1H-imidazole-5-carboxylic acid;

(67) 4-(1-cyclopenten-1-yl)-1-(2,5-dichlorobenzyl)-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(68) 1-(2,5-dichlorobenzyl)-4-(methylthio)-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(69) 1-(2,5-dichlorobenzyl)-4-(ethylthio)-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(70) 1-(2,5-dichlorobenzyl)-4-(2-hydroxypropan-2-yl)-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(71) 1-(2,5-dichlorobenzyl)-4-(3-hydroxypentan-3-yl)-2-(pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(75) 2-(5-fluoropyridin-3-yl)-4-methyl-1-(naphthalen-1-ylmethyl)-1H-imidazole-5-carboxylic acid;

(76) 2-(5-chloropyridin-3-yl)-4-methyl-1-(naphthalen-1-ylmethyl)-1H-imidazole-5-carboxylic acid;

(77) 4-methyl-1-(naphthalen-1-ylmethyl)-2-(5-phenoxypyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(80) 1-(2,5-dichlorobenzyl)-2-(5-fluoropyridin-3-yl)-4-methyl-1H-imidazole-5-carboxylic acid;

(81) 2-(5-chloropyridin-3-yl)-1-(2,5-dichlorobenzyl)-4-methyl-1H-imidazole-5-carboxylic acid;

(82) 1-(2,5-dichlorobenzyl)-2-(5-fluoropyridin-3-yl)-4-(trifluoromethyl)-1H-imidazole-5-carboxylic acid;

(83) 2-(5-chloropyridin-3-yl)-1-(2,5-dichlorobenzyl)-4-(trifluoromethyl)-1H-imidazole-5-carboxylic acid;

(84) 4-methyl-1-(naphthalen-1-ylmethyl)-2-(5-(trifluoromethyl)pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(85) 1-(2,5-dichlorobenzyl)-4-methyl-2-(5-(trifluoromethyl)pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(86) 1-(2,5-dichlorobenzyl)-4-(trifluoromethyl)-2-(5-(trifluoromethyl)pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(90) 2-(5-chloropyridin-3-yl)-4-isopropyl-1-(naphthalen-1-ylmethyl)-1H-imidazole-5-carboxylic acid;

(91) 2-(5-chloropyridin-3-yl)-4-cyclopropyl-1-(naphthalen-1-ylmethyl)-1H-imidazole-5-carboxylic acid;

(92) 2-(5-chloropyridin-3-yl)-1-(2,5-dichlorobenzyl)-4-isopropyl-1H-imidazole-5-carboxylic acid;

(93) 2-(5-chloropyridin-3-yl)-4-cyclopropyl-1-(2,5-dichlorobenzyl)-1H-imidazole-5-carboxylic acid;

(94) 4-ethyl-2-(5-fluoropyridin-3-yl)-1-(naphthalen-1-ylmethyl)-1H-imidazole-5-carboxylic acid;

(95) 2-(5-chloropyridin-3-yl)-4-ethyl-1-(naphthalen-1-ylmethyl)-1H-imidazole-5-carboxylic acid;

(96) 1-(2,5-dichlorobenzyl)-4-ethyl-2-(5-fluoropyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(97) 2-(5-chloropyridin-3-yl)-1-(2,5-dichlorobenzyl)-4-ethyl-1H-imidazole-5-carboxylic acid;

(98) 2-(5-fluoropyridin-3-yl)-4-isopropyl-1-(naphthalen-1-ylmethyl)-1H-imidazole-5-carboxylic acid;

(99) 4-cyclopropyl-2-(5-fluoropyridin-3-yl)-1-(naphthalen-1-ylmethyl)-1H-imidazole-5-carboxylic acid;

(100) 1-(2,5-dichlorobenzyl)-2-(5-fluoropyridin-3-yl)-4-isopropyl-1H-imidazole-5-carboxylic acid;

(101) 4-cyclopropyl-1-(2,5-dichlorobenzyl)-2-(5-fluoropyridin-3-yl)-H-imidazole-5-carboxylic acid;

(102) 1-(2,5-dichlorobenzyl)-4-methyl-2-(5-methylpyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(103) 1-(2,5-dichlorobenzyl)-2-(5-methoxypyridin-3-yl)-4-methyl-1H-imidazole-5-carboxylic acid;

(104) 2-(5-cyanopyridin-3-yl)-1-(2,5-dichlorobenzyl)-4-methyl-1H-imidazole-5-carboxylic acid;

(105) 1-(2,5-dichlorobenzyl)-4-methyl-2-(6-methylpyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(106) 1-(2,5-dichlorobenzyl)-2-(2-fluoropyridin-3-yl)-4-methyl-1H-imidazole-5-carboxylic acid;

(107) 1-(2,5-dichlorobenzyl)-2-(6-methoxypyridin-3-yl)-4-methyl-1H-imidazole-5-carboxylic acid;

(108) 1-(2,5-dichlorobenzyl)-2-(2-methoxypyridin-3-yl)-4-methyl-1H-imidazole-5-carboxylic acid;

(109) 2-(6-chloropyridin-3-yl)-1-(2,5-dichlorobenzyl)-4-methyl-1H-imidazole-5-carboxylic acid;

(111) 1-(2,5-dichlorobenzyl)-4-methyl-2-(5-nitropyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(112) 2-(5-cyclopropylpyridin-3-yl)-1-(2,5-dichlorobenzyl)-4-methyl-1H-imidazole-5-carboxylic acid;

(113) 2-(5-chloropyridin-3-yl)-1-(2,5-dichlorobenzyl)-1H-imidazole-5-carboxylic acid;

(114) 1-(2,5-bis(trifluoromethyl)benzyl)-2-(5-fluoropyridin-3-yl)-4-methyl-1H-imidazole-5-carboxylic acid;

(115) 1-(2,5-dichlorobenzyl)-2-(5-fluoropyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(116) 1-(2,5-dichlorobenzyl)-2-(5-hydroxypyridin-3-yl)-4-methyl-1H-imidazole-5-carboxylic acid;

(117) 1-(2,5-bis(trifluoromethyl)benzyl)-2-(5-chloropyridin-3-yl)-4-methyl-1H-imidazole-5-carboxylic acid;

(118) 1-(2,5-dichlorobenzyl)-2-(5-ethoxypyridin-3-yl)-4-methyl-1H-imidazole-5-carboxylic acid;

(119) 1-(2,5-dichlorobenzyl)-2-(5-isopropoxypyridin-3-yl)-4-methyl-1H-imidazole-5-carboxylic acid;

(120) 1-(2,5-dichlorobenzyl)-4-methyl-2-(5-phenylpyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(121) 2-(5-bromopyridin-3-yl)-1-(2,5-dichlorobenzyl)-4-methyl-1H-imidazole-5-carboxylic acid;

(122) 1-(2,5-dimethylbenzyl)-2-(5-fluoropyridin-3-yl)-4-methyl-1H-imidazole-5-carboxylic acid;

(123) 2-(5-chloropyridin-3-yl)-1-(2,5-dimethylbenzyl)-4-methyl-1H-imidazole-5-carboxylic acid;

(124) 1-(2,5-dimethylbenzyl)-4-methyl-2-(5-methylpyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(125) 1-(2,5-dichlorobenzyl)-2-(5-ethylpyridin-3-yl)-4-methyl-1H-imidazole-5-carboxylic acid;

(126) 1-(2,5-dichlorobenzyl)-4-methyl-2-(5-(methylthio)pyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(127) 2-(5-acetylpyridin-3-yl)-1-(2,5-dichlorobenzyl)-4-methyl-1H-imidazole-5-carboxylic acid;

(128) 1-(2,5-dichlorobenzyl)-4-methyl-2-(5-propoxypyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(129) 1-(2,5-dichlorobenzyl)-2-(5-isobutoxypyridin-3-yl)-4-methyl-1H-imidazole-5-carboxylic acid;

(130) 2-(5-(cyclohexylmethoxy)pyridin-3-yl)-1-(2,5-dichlorobenzyl)-4-methyl-1H-imidazole-5-carboxylic acid;

(131) 2-(5-(benzyloxy)pyridin-3-yl)-1-(2,5-dichlorobenzyl)-4-methyl-1H-imidazole-5-carboxylic acid;

(132) 2-(5-chloropyridin-3-yl)-1-(2,5-dichlorobenzyl)-4-(hydroxymethyl)-1H-imidazole-5-carboxylic acid;

(133) 2-(5-chloropyridin-3-yl)-1-(2,5-dichlorobenzyl)-4-((dimethylamino)methyl)-1H-imidazole-5-carboxylic acid;

(134) 2-(5-chloropyridin-3-yl)-1-(2,5-dichlorobenzyl)-4-((diethylamino)methyl)-1H-imidazole-5-carboxylic acid;

(144) 2-(5-bromopyridin-3-yl)-1-(2,5-dichlorobenzyl)-1H-imidazole-5-carboxylic acid;

(145) 1-(2,5-dichlorobenzyl)-2-(5-methylpyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(146) 2-(5-chloropyridin-3-yl)-1-(2,5-dichlorobenzyl)-4-(difluoromethyl)-1H-imidazole-5-carboxylic acid;

(147) 1-(2,5-dichlorobenzyl)-2-(5-(difluoromethyl) pyridin-3-yl)-4-methyl-1H-imidazole-5-carboxylic acid;

(148) 2-(5-chloropyridin-3-yl)-1-(2,5-dichlorobenzyl)-4-ethynyl-1H-imidazole-5-carboxylic acid;

(149) 2-(5-chloropyridin-3-yl)-1-(2,5-dichlorobenzyl)-1H-imidazole-4,5-dicarboxylic acid;

(150) 2-(5-chloropyridin-3-yl)-1-(2,5-dichlorobenzyl)-4-(1-hydroxyethyl)-1H-imidazole-5-carboxylic acid;

(151) 1-(2,5-dichlorobenzyl)-2-(5-fluoropyridin-3-yl)-4-(2-hydroxypropan-2-yl)-1H-imidazole-5-carboxylic acid;

(152) 2-(5-chloropyridin-3-yl)-1-(2,5-dichlorobenzyl)-4-(2-hydroxypropan-2-yl)-1H-imidazole-5-carboxylic acid;

(153) 1-(2,5-dichlorobenzyl)-4-(2-hydroxypropan-2-yl)-2-(5-methylpyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(154) 1-(2,5-dichlorobenzyl)-2-(5-fluoropyridin-3-yl)-4-(3-hydroxypentan-3-yl)-1H-imidazole-5-carboxylic acid;

(155) 2-(5-chloropyridin-3-yl)-1-(2,5-dichlorobenzyl)-4-(3-hydroxypentan-3-yl)-1H-imidazole-5-carboxylic acid;

(156) 1-(2,5-dichlorobenzyl)-4-(3-hydroxypentan-3-yl)-2-(5-methylpyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(157) 4-acetyl-2-(5-chloropyridin-3-yl)-1-(2,5-dichlorobenzyl)-1H-imidazole-5-carboxylic acid;

(158) 4-chloro-1-(2,5-dichlorobenzyl)-2-(5-methylpyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(159) 4-chloro-2-(5-chloropyridin-3-yl)-1-(2,5-dichlorobenzyl)-1H-imidazole-5-carboxylic acid;

(161) 2-(5-chloropyridin-3-yl)-1-(1-(2,5-dichlorophenyl)ethyl)-4-methyl-1H-imidazole-5-carboxylic acid;

(168) 1-(2-chloro-5-methylbenzyl)-4-methyl-2-(5-methylpyridin-3-yl)-1H-imidazole-5-carboxylic acid;

(169) 1-(2-chloro-5-methylbenzyl)-2-(5-chloropyridin-3-yl)-4-methyl-1H-imidazole-5-carboxylic acid;

(191) 2-((2-(5-chloropyridin-3-yl)-1-(2,5-dichlorobenzyl)-1H-imidazole-5-yl)thio)-2-methylpropanoic acid;

(192) 1-((2-(5-chloropyridin-3-yl)-1-(2,5-dichlorobenzyl)-1H-imidazol-5-yl)thio)cyclobutanecarboxylic acid; and

(193) 2-((5-(5-chloropyridin-3-yl)-1-(2,5-dichlorobenzyl)-1H-imidazol-2-yl)thio)-2-methylpropanoic acid.

10. A pharmaceutical composition comprising the pyridine derivative, or the pharmaceutically acceptable salt thereof, according to claim 1 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2018
From: TEIJIN PHARMA LIMITED
To: TEIJIN LIMITED
Reel/Frame 047322/0604 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2015
From: MARUYAMA, AKINOBU; KAMADA, HIROFUMI; FUJINUMA, MIKA; TAKEUCHI, SUSUMU; SAITOH, HIROSHI; TAKAHASHI, YOSHIMASA
To: TEIJIN PHARMA LIMITED
Reel/Frame 035578/0449 →
Priority Claims (1)
JP 2012-250661 · Nov 14, 2012 · national
Continuity (1)
Related Publication 20150284358A1 · Oct 8, 2015